Positive context积极背景
Stocks股票 / Health Care / BCRX
Biocryst Pharmaceuticals Inc · Health Care
BCRX US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
$8.59
+$0.07 · +0.82%
52w low52周低 $6.10high高 $11.38
Neutral — no clear edge中性 — 无明显优势
Trend intact — hold; add on dips toward the 10-day average.趋势完好——持有；可在回调至 10 日均线附近时加仓。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
41
Neutral zone中性区域
vs 50-day average相对50日均线
-7.9% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
-0.9% below下方
Long trend down长期向下
Volatility波动率
53th percentile第53百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0235
Mixed — beat 2 of last 4 quarters表现不稳 — 近 4 季中 2 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 362.5%
Financials财务数据
fiscal years财年Revenue营业收入
$874.8M2025
20202025
5-yr growth5年复合增速 117.9%
Earnings per share每股收益
$1.212025
20202025
Free cash flow自由现金流
$344.9M2025
20202025
Operating margin营业利润率
39.0%
Balance-sheet quality财务体质 7/9
Return on equity股本回报率 -221%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.26
Current ratio流动比率2.06
Capital allocation资本配置
Stock-based comp股权薪酬$85.1M
Share count change (1y)股数变化（1年）+2.2%
Debt coming due到期债务
FY2019 10-KIn the 12-month bucket following fiscal period end 2019-12-31, it reported $10.0M due — about 20% of its disclosed principal.在财年期末 2019-12-31 之后12个月的区间内，已披露到期本金为 $10.0M，约占其披露本金的 20%。
All maturity buckets are measured from fiscal period end 2019-12-31, not from today.所有到期区间均从财年期末 2019-12-31 起算，而非从今天起算。
First 12 months after period end报告期末之后首12个月
$10.0M
Year 2第2年
$20.0M
Year 3第3年
$20.0M
Year 4第4年
not reported未披露
Year 5第5年
not reported未披露
After year 55年以后
not reported未披露
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整；不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考；缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实，不跨文件拼接。文件
0001171843-20-001710, period ending报告期截至 2019-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-21T09:32:03.960823+00:00.
3/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThreeLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— absent
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
BCRX lost its 200-day averageBCRX 跌破200日均线
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$2.6M net (0 buyers, 3 sellers)-$2.6M 净值（0 买家，3 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | Adding加仓 | 1.6% | 2026-06-30 |
| RA Capital Management | D | Holding持有 | 1.4% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD. Day 10 of the cycle, trend intact above a rising 10-day average, weekly still mixed. Last cycle was left-translated (topped early) — a bearish structural tell持有。周期第 10 天，趋势完好并位于向上的 10 日均线之上，周线仍为混合。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Sep 23, 2026
BCRX lost its 200-day averageBCRX 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $8.57.收盘跌破200日均线 — 经典的空头分界线。$8.57。
Sep 23, 2026
BCRX broke down vs the marketBCRX 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $8.57.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$8.57。
Sep 18, 2026
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 17, 2026
BCRX reclaimed its 200-day averageBCRX 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $8.70.收盘重回200日均线 — 经典的多头分界线。$8.70。
Sep 17, 2026
BCRX StochRSI turned up from oversoldBCRX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $8.70.StochRSI重回20上方 — 下行动量趋缓的最早预警。$8.70。
Sep 11, 2026
BCRX printed a daily-cycle lowBCRX 打出日线周期低点
A confirmed local low — in this cycle framework the highest-odds long-entry window. $8.12.一个已确认的局部低点 — 在本周期框架中做多胜率最高的入场窗口。$8.12。
Sep 11, 2026
BCRX weekly MACD crossed downBCRX 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Sep 11, 2026
BCRX RSI reached oversoldBCRX RSI进入超卖
RSI(14) crossed below 30 — washed out; context, not a timing trigger alone. $8.12.RSI(14)下穿30 — 超卖；仅作背景，单独不构成择时。$8.12。
Sep 10, 2026
NEARING A LOW → DOWNTREND接近低点 → 下跌趋势
AVOID回避
Sep 10, 2026
BCRX lost its 200-day averageBCRX 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $8.29.收盘跌破200日均线 — 经典的空头分界线。$8.29。
Sep 10, 2026
BCRX broke down vs the marketBCRX 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $8.29.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$8.29。
Sep 9, 2026
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY准备
Sep 8, 2026
UPTREND → UNCONFIRMED TURN上涨趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 8, 2026
BCRX daily MACD crossed downBCRX 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $9.07.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$9.07。
Showing the last 15 of显示最近15条，共 176 signals条信号
Company profile公司档案
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -1.0% | +1.3% |
| 1 Month近1月 | -12.6% | +0.9% |
| 3 Months近3月 | -13.6% | +6.1% |
| 6 Months近6月 | -7.9% | +22.3% |
| Year to date年初至今 | +14.5% | +13.8% |
| 1 Year近1年 | +12.3% | +18.5% |
Trading information交易信息
Volatility rank波动率分位
53th pctile
EPS (trailing)每股收益
$1.24
Off 52-week high距52周高点
-22.7%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $18M | $157M | $271M | $331M | $451M | $875M |
| EPS每股收益 | $-1.09 | $-1030.00 | $-1.33 | $-1.18 | $-0.43 | $1.21 |
| Free cash flow自由现金流 | $-138M | $-145M | $-163M | $-97M | $-53M | $345M |
| Gross margin毛利率 | 91.3% | 95.4% | 97.6% | 98.6% | 97.3% | 97.8% |
| Net margin净利率 | -1026.4% | -117.1% | -91.2% | -68.4% | -19.7% | 30.2% |
| FCF margin自由现金流利润率 | -773.2% | -92.0% | -60.3% | -29.4% | -11.8% | 39.4% |
Latest fiscal year最近财年
Net income净利润
$264M
Operating cash flow经营现金流
$347M
Total assets总资产
$514M
Shareholder equity股东权益
$-119M
Long-term debt长期负债
$0
Shares outstanding总股本
0.21B
Returns & growth回报与增长
Return on equity股本回报率
-221.4%
Return on assets资产回报率
51.3%
Debt / assets负债/资产
0.0%
Asset growth资产增速
+4.8%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Working capital: inventory & receivables lean vs sales营运资本：存货与应收相对销售保持精简
- Pricing power: gross margin +6.5pts over 6 years定价能力：毛利率 6 年上升 6.5 个百分点
- Capital discipline: share count +20.5% over 6 years (dilution)资本纪律：股本 6 年增加 20.5%（稀释）
- Balance sheet: leverage unremarkable资产负债表：杠杆水平一般
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
41
RSI (2-day)RSI（2日）
52
vs 20-day average相对20日均线
-4.2%
vs 50-day average相对50日均线
-7.9%
vs 200-day average相对200日均线
-0.9%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down — turning up soon动能向下——接近转强
3-day3日线
momentum down动能向下
Weekly周线
momentum down — fresh downturn动能向下——刚刚转弱
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
92/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.30 | $0.14 | +114.3% |
| Mar 2026 | $-0.03 | $0.06 | -150.0% |
| Dec 2025 | $1.12 | $0.07 | +1500.0% |
| Sep 2025 | $0.06 | $0.07 | -14.3% |
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Perceptive Advisors | A | Adding增持 | 1.6% | $103M |
| RA Capital Management | D | Holding持有 | 1.4% | $158M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
1 : 0
Quarterly trend季度趋势
{'direction': 'accumulating', 'n_quarters': 12, 'holders_first': 1, 'holders_last': 2, 'holders_delta': 1, 'value_change_pct': 190.4, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2023-11-15', 'holders_series': [1, 1, 1, 1, 1, 0, 0, 0, 0, 3, 2, 2]}{'direction': 'accumulating', 'n_quarters': 12, 'holders_first': 1, 'holders_last': 2, 'holders_delta': 1, 'value_change_pct': 190.4, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2023-11-15', 'holders_series': [1, 1, 1, 1, 1, 0, 0, 0, 0, 3, 2, 2]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$2.6M
Insider buyers vs sellers内部人买家vs卖家
0 : 3
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。